Effects of anti-secretory factor (ASF) on irritable bowel syndrome (IBS). A double-blind, randomized study
- PMID: 18570009
- PMCID: PMC3406645
- DOI: 10.1080/02813430802005894
Effects of anti-secretory factor (ASF) on irritable bowel syndrome (IBS). A double-blind, randomized study
Abstract
Objective: To evaluate the role of the endogenous protein anti-secretory factor (ASF) on the symptoms, especially loose stools, in irritable bowel ayndrome (IBS).
Design: A diet with specially processed cereals (SPC) known to induce ASF production was used in patients with IBS, in an eight-week randomized, placebo-controlled study.
Subjects: Eighty-two patients with IBS were randomized to a diet with either SPC or placebo.
Main outcome measures: The overall clinical condition and the quality of life were measured by VAS and SF-36 questionnaire, respectively. The plasma levels of ASF were determined in 14 patients with dominating loose stools before and after diet.
Results: All patients significantly (p<0.001) improved in IBS-related symptoms irrespective of active or placebo diet. In an active-diet sub-group with diarrhoea (n=11) there was a significant (p<0.05) correlation between the increase of plasma ASF level and the improvement on the VAS.
Conclusion: Both study groups improved significantly on the VAS but no additive effect was seen for the active treatment. In the sub-group with loose stools, the SPC diet induced ASF plasma levels in IBS patients and was correlated to significant symptom improvement in the individual patient.
Similar articles
-
The effect of dietary glutamate on fibromyalgia and irritable bowel symptoms.Clin Exp Rheumatol. 2012 Nov-Dec;30(6 Suppl 74):10-7. Epub 2012 Dec 14. Clin Exp Rheumatol. 2012. PMID: 22766026 Clinical Trial.
-
A diet low in FODMAPs reduces symptoms of irritable bowel syndrome.Gastroenterology. 2014 Jan;146(1):67-75.e5. doi: 10.1053/j.gastro.2013.09.046. Epub 2013 Sep 25. Gastroenterology. 2014. PMID: 24076059 Clinical Trial.
-
Fecal Microbiota Transplantation Reduces Symptoms in Some Patients With Irritable Bowel Syndrome With Predominant Abdominal Bloating: Short- and Long-term Results From a Placebo-Controlled Randomized Trial.Gastroenterology. 2021 Jan;160(1):145-157.e8. doi: 10.1053/j.gastro.2020.07.013. Epub 2020 Jul 15. Gastroenterology. 2021. PMID: 32681922 Clinical Trial.
-
Effect of vitamin D on gastrointestinal symptoms and health-related quality of life in irritable bowel syndrome patients: a randomized double-blind clinical trial.Neurogastroenterol Motil. 2016 Oct;28(10):1533-44. doi: 10.1111/nmo.12851. Epub 2016 May 7. Neurogastroenterol Motil. 2016. PMID: 27154424 Clinical Trial.
-
Food supplements and diet as treatment options in irritable bowel syndrome.Neurogastroenterol Motil. 2020 Aug;32(8):e13951. doi: 10.1111/nmo.13951. Neurogastroenterol Motil. 2020. PMID: 32697018 Review.
Cited by
-
Antisecretory Factor Modulates GABAA Receptor Activity in Neurons.J Mol Neurosci. 2018 Feb;64(2):312-320. doi: 10.1007/s12031-017-1024-8. Epub 2018 Jan 7. J Mol Neurosci. 2018. PMID: 29308551
References
-
- Oddsson E, Rask-Madsen J, Krag E. A secretory epithelium of the small intestine with increased sensitivity to bile acids in irritable bowel syndrome associated with diarrhoea. Scand J Gastroenterol. 1978;13:408–16. - PubMed
-
- Agréus L, Svärdsudd K, Nyrén O, et al. Irritable bowel syndrome and dyspepsia in the general population: Overlap and lack of stability over time. Gastroenterology. 1995;109:671–80. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources